SEC Form 4 · accession 0001379372-15-000002
MYRIAD GENETICS INC · MYGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Heinrich Dreismann
Director
Period of report
Nov 5, 2015
Accepted (ET)
Nov 5, 2015 · 6:14 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000899923
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 5, 2015 | M | 30,000 | $25.39 | A | 40,000 | D | |
| Common Stock | Nov 5, 2015 | S | 30,000 | $44.4353 | D | 10,000 | D | |
| Common Stock | Nov 5, 2015 | M | 30,000 | $27.61 | A | 40,000 | D | |
| Common Stock | Nov 5, 2015 | S | 30,000 | $44.4353 | D | 10,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) | $25.39 | Nov 5, 2015 | M | 30,000 | D | Dec 5, 2014 | Dec 5, 2021 | Common Stock | 30,000 | 0 | D |
| Non-Qualified Stock Option (right to buy) | $27.61 | Nov 5, 2015 | M | 30,000 | D | Dec 5, 2013 | Dec 5, 2022 | Common Stock | 30,000 | 0 | D |